DDD 3D Systems Corporation

3D Systems Names Michael Turner as Chief Financial Officer

3D Systems Names Michael Turner as Chief Financial Officer

ROCK HILL, S.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today that Michael Turner will join the company as Executive Vice President and Chief Financial Officer, effective August 29, 2022. He will report to President and CEO, Dr. Jeffrey Graves, and will lead the company’s global finance organization, including accounting and controllership, financial planning, tax, treasury, and investor relations.

Michael brings an exemplary technical background to the CFO role that includes public accounting experience as well as financial leadership roles of increasing responsibility at both public and private companies. Currently, Michael is Chief Financial Officer of Innovative Chemical Products (ICP), a leading developer and manufacturer of specialty coatings, adhesives, and sealants serving major industrial and construction end markets. Prior to that, Michael was a finance executive at the publicly traded chemical company Albemarle Corporation, where his roles included business unit Chief Financial Officer, Vice President of Corporate FP&A, and Finance Leader for the company’s global Enterprise Resource Planning (ERP) technology implementation. Michael’s 20-plus-year finance career also includes financial leadership positions as divisional and corporate controller at FMC Corporation and Polypore International, respectively.

“I am delighted to have a well-rounded and seasoned financial leader such as Michael join 3D Systems,” said Dr. Graves. “Michael possesses deep expertise in driving strong financial controls and governance and in implementing technology-based strategies to transform finance organizations. His background will prove invaluable as we continue to invest in our corporate infrastructure to support the attractive growth trajectory we envision both for our company and the additive manufacturing industry as a whole.”

“In addition,” noted Dr. Graves, “I want to express my sincere gratitude to Wayne Pensky for his service as our interim CFO. I greatly appreciate Wayne’s leadership during this period of transition, as well as the support that he will provide to Michael to ensure a seamless transition in the weeks ahead.”

Forward-Looking Statements

Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.

About 3D Systems

More than 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at .

Investor Contact:

Media Contact:

     

   

A photo accompanying this announcement is available at



EN
04/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 3D Systems Corporation

 PRESS RELEASE

3D Systems to Participate Virtually at William Blair’s “What’s Next fo...

3D Systems to Participate Virtually at William Blair’s “What’s Next for Industrials” Conference ROCK HILL, S.C., Sept. 16, 2022 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today that management will participate in a panel during William Blair’s “What’s Next for Industrials” Conference. The panel, titled “Advancing Healthcare Through 3D Bioprinting,” will take place virtually on Friday, September 23, 2022, at 12:00 p.m. Eastern Time. A recording of the panel will be available on the "Events and Presentations" section of 3D Systems’ website at shortly after conclusion of the event and wil...

 PRESS RELEASE

3D Systems Announces Appointment of Andrew Johnson as Chief Corporate ...

3D Systems Announces Appointment of Andrew Johnson as Chief Corporate Development Officer ROCK HILL, S.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Today, (NYSE:DDD) announced that Andrew Johnson, the company’s executive vice president, chief legal officer, is taking on expanded responsibilities as chief corporate development officer. In this role, he will not only lead the company’s mergers and acquisitions but will also lead the establishment of new strategic partnerships in support of the company’s expanding business needs. Mr. Johnson has been with 3D Systems for more than 16 years, and du...

 PRESS RELEASE

3D Systems Expands Industry-leading Materials Portfolio with Introduct...

3D Systems Expands Industry-leading Materials Portfolio with Introduction of New Production-grade Materials Figure 4® Tough Clear – first production-grade, clear material in Figure 4 portfolio - opens new industrial applications requiring long-term use partsCompany builds on open materials strategy for selective laser sintering with DuraForm® PAx Black - lower cost, highly recyclable nylon copolymer for industrial applications ROCK HILL, S.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Today, (NYSE:DDD) announced and – two new production-grade materials designed to address a breadth of indu...

 PRESS RELEASE

3D Systems Announces Formation of New Biotech Company, Systemic Bio™, ...

3D Systems Announces Formation of New Biotech Company, Systemic Bio™, to Accelerate Drug Discovery and Development New company will leverage 3D Systems’ recent breakthroughs in bioprinting of vascularized human organs and tissues to accelerate new drug development, reduce costs, and ultimately reduce or eliminate the need for animal testingUnique bioprinted organ-on-a-chip platform, h-VIOS™, created using hydrogels to produce complex vasculature that supports extended life in healthy or diseased human cells for use in drug studies3D Systems to provide $15 million in seed funding to demonstr...

 PRESS RELEASE

3D Systems Announces First to Market CuNi (CuNi30) Alloy for Laser Pow...

3D Systems Announces First to Market CuNi (CuNi30) Alloy for Laser Powder Bed Fusion 3D Systems & HII co-developed CuNi30 to enable production of traditionally cast parts, potentially reducing lead time by up to 75%Direct metal printing of copper-nickel (CuNi30) results in average relative density of 99.88% - a significant improvement compared to castingMaterial to be commercially available to address existing need for CuNi casting alternatives in marine, offshore oil & gas, and chemical & nuclear industries ROCK HILL, S.C., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Today, (NYSE:DDD) is please...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch